Contraceptive Technology Update – August 1, 2009
August 1, 2009
View Issues
-
Science eyes HPV vaccine use in men — Will shot be approved for U.S. males?
Family planning clinicians have become familiar with providing Gardasil (Merck & Co.), the quadrivalent vaccine for human papillomavirus (HPV), to young women. Will their practice extend to include young men if the vaccine is approved by the Food and Drug Administration (FDA)? -
Science circles in on vaginal ring technology
What if a vaginal ring could deliver protection against unplanned pregnancy and HIV infection? Scientists are testing a ring loaded with multiple antiviral drugs to prevent HIV infection, and they also are weighing its use in pregnancy prevention. -
New progestins eyed for contraception in U.S.
While not yet available in the United States, international researchers are examining use of contraceptive progestins in two birth control methods: a transdermal patch using gestodene and an oral contraceptive formulation using dienogest. -
Express STI testing: Can it work in your clinic?
Look out in the waiting room of your clinic. How many patients are waiting to be seen by a provider to be tested for a sexually transmitted infection (STI)? -
Talking new technology: Reach teens via new media
Wondering how to get prevention messages to adolescents? Public health officials are looking at new approaches such as text messaging on cell phones and Internet social networking sites to reach, educate, and engage teens regarding their sexual and reproductive health. -
Continue screening for syphilis in pregnancy
What is included in your practice during a first prenatal visit? If syphilis screening is not on the list, be sure to add it. Following a systematic review of current evidence, the U.S. Preventive Services Task Force has just reaffirmed its 2004 recommendation that clinicians screen all pregnant women for syphilis infection.